Patient with long-term response treated with axitinib

dc.contributor.authorRichter Igorcs
dc.contributor.authorDvořák Josefcs
dc.date.accessioned2020-06-08T09:46:01Z
dc.date.available02-31-2020en
dc.date.available2020-06-08T09:46:01Z
dc.date.issued2020cs
dc.date.updated05-59-2020en
dc.format.extent4cs
dc.identifier.issn1805-398Xcs
dc.identifier.urihttps://dspace.tul.cz/handle/15240/156244
dc.language.isoczecs
dc.publisherFaculty of Medicinecs
dc.publisher.cityHradec Královécs
dc.relation.ispartofActa medicinaeen
dc.relation.ispartofseries0cs
dc.subjectmetastatic renal cell carcinomacs
dc.subjecttargeted treatmentcs
dc.subjectimmunotherapycs
dc.subjectlong-term response ratecs
dc.subjectaxitinibcs
dc.titlePatient with long-term response treated with axitiniben
dc.titleKazuistika s dlouhodobou léčebnou odpovědí na terapii axitinibemcs
local.citation.epage15-18cs
local.citation.spage15-18cs
local.identifier.publikace6952
local.relation.issue4cs
Files
Collections